Suppr超能文献

青光眼的蛋白质生物标志物:综述

Protein Biomarkers in Glaucoma: A Review.

作者信息

Fiedorowicz Ewa, Cieślińska Anna, Kuklo Patrycja, Grzybowski Andrzej

机构信息

Department of Biochemistry, Faculty of Biology and Biotechnology, University of Warmia and Mazury, Oczapowskiego 1A Street, 10-719 Olsztyn, Poland.

Department of Ophthalmology, University of Warmia and Mazury, 10-719 Olsztyn, Poland.

出版信息

J Clin Med. 2021 Nov 18;10(22):5388. doi: 10.3390/jcm10225388.

Abstract

Glaucoma is a multifactorial disease. Early diagnosis of this disease can support treatment and reduce the effects of pathophysiological processes. A significant problem in the diagnosis of glaucoma is limited access to the tested material. Therefore, intensive research is underway to develop biomarkers for fast, noninvasive, and reliable testing. Biomarkers indicated in the formation of glaucoma include chemical compounds from different chemical groups, such as proteins, sugars, and lipids. This review summarizes our knowledge about protein and/or their protein-like derived biomarkers used for glaucoma diagnosis since 2000. The described possibilities resulting from a biomarker search may contribute to identifying a group of compounds strongly correlated with glaucoma development. Such a find would be of great importance in the diagnosis and treatment of this disorder, as current screening techniques have low sensitivity and are unable to diagnose early primary open-angle glaucoma.

摘要

青光眼是一种多因素疾病。该疾病的早期诊断有助于治疗并减轻病理生理过程的影响。青光眼诊断中的一个重大问题是获取检测材料的途径有限。因此,目前正在进行深入研究以开发用于快速、无创且可靠检测的生物标志物。在青光眼形成过程中显示出的生物标志物包括来自不同化学类别的化合物,如蛋白质、糖类和脂质。本综述总结了自2000年以来我们对用于青光眼诊断的蛋白质和/或其类蛋白衍生生物标志物的认识。生物标志物搜索所产生的上述可能性可能有助于识别与青光眼发展密切相关的一组化合物。这样的发现对于该疾病的诊断和治疗具有重要意义,因为目前的筛查技术灵敏度较低,无法诊断早期原发性开角型青光眼。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e5b/8624910/509b18ee9979/jcm-10-05388-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验